Evolution of risk prediction models for post-operative mortality in patients with cirrhosis.


Journal

Hepatology international
ISSN: 1936-0541
Titre abrégé: Hepatol Int
Pays: United States
ID NLM: 101304009

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 13 09 2022
accepted: 24 01 2023
medline: 29 5 2023
pubmed: 28 3 2023
entrez: 27 3 2023
Statut: ppublish

Résumé

The perception of high surgical risk among patients with cirrhosis has resulted in a long-standing reluctance to operate. Risk stratification tools, first implemented over 60 years ago, have attempted to assess mortality risk among cirrhotic patients and ensure the best possible outcomes for this difficult to treat cohort. Existing postoperative risk prediction tools including the Child-Turcotte-Pugh (CTP) and Model for End-stage Liver Disease (MELD) provide some prediction of risk in counselling patients and their families but tend to overestimate surgical risk. More personalised prediction algorithms such as the Mayo Risk Score and VOCAL-Penn score that incorporate surgery-specific risks have demonstrated a significant improvement in prognostication and can ultimately aid multidisciplinary team determination of potential risks. The development of future risk scores will need to incorporate, first and foremost, predictive efficacy, but perhaps just as important is the feasibility and usability by front-line healthcare professionals to ensure timely and efficient prediction of risk for cirrhotic patients.

Identifiants

pubmed: 36971983
doi: 10.1007/s12072-023-10494-0
pii: 10.1007/s12072-023-10494-0
pmc: PMC10224863
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

542-545

Informations de copyright

© 2023. The Author(s).

Références

Clin Gastroenterol Hepatol. 2019 Mar;17(4):595-606
pubmed: 30273751
Nat Clin Pract Gastroenterol Hepatol. 2007 May;4(5):266-76
pubmed: 17476209
N Engl J Med. 1961 Oct 12;265:721-8
pubmed: 14040163
Liver Transpl. 2021 May;27(5):699-710
pubmed: 33226691
Major Probl Clin Surg. 1964;1:1-85
pubmed: 4950264
J Gastrointest Surg. 2019 Mar;23(3):634-642
pubmed: 30465191
Liver Int. 2019 Aug;39(8):1394-1399
pubmed: 31141306
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
J Hepatol. 2019 Nov;71(5):942-950
pubmed: 31330170
Liver Int. 2011 Feb;31(2):222-8
pubmed: 21134111
J Hepatol. 2019 Oct;71(4):707-718
pubmed: 31199941
Gastroenterology. 2007 Apr;132(4):1261-9
pubmed: 17408652
Hepatology. 2021 Jan;73(1):7-9
pubmed: 33220099
Liver Transpl. 2021 Jul;27(7):961-970
pubmed: 33788365
Hepatology. 2021 Jan;73(1):204-218
pubmed: 32939786
Clin Gastroenterol Hepatol. 2022 May;20(5):e1121-e1134
pubmed: 34246794

Auteurs

Eric Kalo (E)

Blacktown Clinical School, School of Medicine, Western Sydney University, Blacktown, NSW, 2148, Australia.

Jacob George (J)

Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia.

Scott Read (S)

Blacktown Clinical School, School of Medicine, Western Sydney University, Blacktown, NSW, 2148, Australia.
Blacktown Hospital, Western Sydney Local Health District, Blacktown, NSW, 2148, Australia.
Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia.

Avik Majumdar (A)

Victorian Liver Transplant Unit, Austin Health, Heidelberg, VIC, 3181, Australia.
The University of Melbourne, Melbourne, VIC, 3010, Australia.

Golo Ahlenstiel (G)

Blacktown Clinical School, School of Medicine, Western Sydney University, Blacktown, NSW, 2148, Australia. g.ahlenstiel@westernsydney.edu.au.
Blacktown Hospital, Western Sydney Local Health District, Blacktown, NSW, 2148, Australia. g.ahlenstiel@westernsydney.edu.au.
Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia. g.ahlenstiel@westernsydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH